A device for tracking radiation doses to organs during treatment.
The Personalized Remote Radiation Tracking Portable Organ Dosimetry Devise (PRRT PODD)
This study is testing a handy device that helps keep track of how much radiation your organs receive during treatment for neuroendocrine tumors, so your doctors can create a more personalized plan that works best for you while reducing side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10988083 on NIH RePORTER |
What this research studies
This research focuses on developing a portable device that tracks radiation doses to organs during targeted therapies for neuroendocrine tumors. By using advanced imaging techniques, the device aims to personalize treatment plans based on individual organ dosimetry, potentially improving patient outcomes. The approach involves quantifying radiation exposure to organs at risk and tumors, allowing for tailored therapy that maximizes effectiveness while minimizing side effects. Patients will be monitored throughout their treatment to ensure optimal dosing.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with neuroendocrine tumors who are undergoing treatment with 177Lu-DOTATATE.
Not a fit: Patients who do not have neuroendocrine tumors or are not receiving targeted radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective radiation treatments for patients with neuroendocrine tumors.
How similar studies have performed: Previous studies have shown promising results in personalizing radiation therapy, indicating that this approach could be effective.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Miyaoka, Robert S — University of Washington
- Study coordinator: Miyaoka, Robert S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.